Rhythm Pharmaceuticals Inc (RYTM) — Quality & forensics
As of 2026-10-08 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 6
- Quality 21
- Growth 72
- Balance sheet 60
- Cash quality 65
- Capital allocation 8
- Momentum 41
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the RYTM chart & overview · the earnings record
FAQ · from the current data · as of 2026-10-08
Quick answers
What is Rhythm Pharmaceuticals Inc's Closelooknet quality reading?
The composite reads 40/100 across 7 modules, as of 2026-10-08: valuation 6, quality 21, growth 72, balance sheet 60, cash quality 65, capital allocation 8, momentum 41. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Rhythm Pharmaceuticals Inc's Altman Z-Score?
14.40, which sits in the safe zone (above 2.99) as of 2026-10-08. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Rhythm Pharmaceuticals Inc's Piotroski F-Score?
5 of 8, as of 2026-10-08. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Rhythm Pharmaceuticals Inc's Beneish M-Score indicate?
-2.88 — below the −1.78 manipulation-risk threshold, as of 2026-10-08. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- BION.SW BB Biotech AGindustry
- ONC BeiGene, Ltd.industry
- KRYS Krystal Biotech Incindustry
- PTGX Protagonist Therapeutics Incindustry
- REGN Regeneron Pharmaceuticals Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- RXRX Recursion Pharmaceuticals Incindustry
- TWST Twist Bioscience Corpindustry
- EXEL Exelixis Incindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- APGE APGE.USindustry
- BANB.SW Bachem Holding AGindustry
- TECH Bio-Techne Corpindustry
- VRTX Vertex Pharmaceuticals Incindustry
- RPRX Royalty Pharma Plcindustry
- INCY Incyte Corporationindustry
- JAZZ Jazz Pharmaceuticals PLCindustry